Milestone Pharmaceuticals Inc (MIST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 119,818 | 85,947 | 10,880 | N/A |
| Marketable Securities | N/A | 29 | 16,032 | N/A |
| Receivables | 258 | 387 | 116 | N/A |
| Other current assets | 578 | 290 | 427 | 0 |
| TOTAL | $122,499 | $88,051 | $27,555 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 405 | 30 | 35 | N/A |
| Other Non-Current Assets | 524 | 0 | 0 | 0 |
| TOTAL | $929 | $30 | $35 | $N/A |
| Total Assets | $123,428 | $88,081 | $27,590 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 7,997 | 4,477 | 1,601 | 0 |
| TOTAL | $8,327 | $4,533 | $1,605 | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 184 | 138,758 | 59,104 | 0 |
| TOTAL | $184 | $138,758 | $59,104 | $N/A |
| Total Liabilities | $8,511 | $143,291 | $60,709 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 24,559 | N/A | N/A | N/A |
| Common Shares | 226,245 | 2,039 | 1,228 | N/A |
| Retained earnings | -113,499 | -58,270 | -35,085 | N/A |
| Other shareholders' equity | -1,634 | -1,634 | -1,634 | 0 |
| TOTAL | $114,917 | $-55,210 | $-33,119 | $N/A |
| Total Liabilities And Equity | $123,428 | $88,081 | $27,590 | $0 |